Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSX:OBE
TSX:OBEOil and Gas

Exploring Global Undervalued Small Caps With Insider Action In January 2026

As 2026 kicks off, global markets are experiencing a robust rally, with small-cap stocks leading the charge as evidenced by the Russell 2000 Index's impressive 5.73% gain. Despite signs of a cooling U.S. labor market and ongoing geopolitical tensions, investor optimism remains buoyant, particularly for small-cap and value shares that have outpaced their large-cap counterparts. In this dynamic environment, identifying promising small-cap stocks often involves looking at companies that...
SZSE:300072
SZSE:300072Chemicals

Global Penny Stocks To Watch: 3 Picks Under US$2B Market Cap

As global markets kick off the year with a rally, small-cap and value shares are capturing investors' attention, outpacing their larger counterparts. In this context, penny stocks—often representing smaller or newer companies—continue to attract interest for their potential to offer unique opportunities. Although the term "penny stocks" might seem outdated, these investments remain relevant for those seeking under-the-radar companies with solid financial foundations. This article will explore...
ASX:TTT
ASX:TTTChemicals

How Titomic’s (ASX:TTT) European Leadership Refresh Could Shape Its Global Execution Story

Titomic Limited has announced leadership changes within its European division, with Chris Myers becoming President of Titomic Europe in early 2026 and Ferdy Touwen promoted to Deputy President & Head of European Operations, while outgoing leader Klaas Rozema moves into a Senior Executive Advisor role ahead of a planned sabbatical. This reshaping of Titomic’s European leadership concentrates commercial and operational responsibility in a refreshed team, aiming to support execution, customer...
NasdaqGM:ARCT
NasdaqGM:ARCTBiotechs

Does Arcturus Therapeutics (ARCT) JPM Conference Spotlight Clarify Its Long-Term Platform Credibility?

Arcturus Therapeutics Holdings Inc. recently presented at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at the Westin St. Francis Hotel in San Francisco, with Founder, President, CEO and Director Joseph E. Payne speaking. This high-profile conference appearance offered Arcturus a platform to showcase its pipeline and corporate story to a concentrated audience of healthcare-focused investors and industry peers. With this conference spotlight and recent share price...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

How Investors May Respond To Masimo (MASI) Record Hospital Contracts And Preliminary 2025 Revenue Growth

Masimo Corporation has already presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and released preliminary fourth-quarter and full-year 2025 results indicating approximately 12% quarterly and 9% annual revenue growth. Management also highlighted a record level of incremental contract value from new and expanded hospital agreements, underscoring the importance of long-term customer relationships to the business. We’ll now examine how the record incremental...
OTCPK:HONT
OTCPK:HONTBanks

Honat Bancorp (OTCPK:HONT) Earnings Growth Outpaces Long Run Trend And Fuels Margin Expansion Narrative

Honat Bancorp (HONT) has put another solid quarter on the board, with Q2 2025 revenue of US$11.4 million and basic EPS of US$2.57 feeding into trailing twelve month EPS of US$10.46 on revenue of US$44.6 million and net income of US$15.0 million. Over the past year, the company has seen revenue move from US$38.8 million to US$44.6 million on a trailing basis, while EPS climbed from US$8.33 to US$10.46, and earnings growth of 19% has supported a net profit margin of 33.5% compared with 31.2% a...
SWX:SIKA
SWX:SIKAChemicals

Is It Time To Reassess Sika (SWX:SIKA) After A 30% One Year Share Price Slide?

If you have been wondering whether Sika shares are now offering value or still look expensive, this breakdown will help you put the current price into context before you commit fresh capital. Sika shares last closed at CHF149.10, with returns of an 8.7% decline over 7 days, a 6.7% decline over 30 days, an 8.9% decline year to date, and a 30.8% decline over 1 year, adding to a 39.6% decline over 3 years and a 35.0% decline over 5 years. Recent coverage around Sika has focused on its position...
LSE:BAKK
LSE:BAKKFood

January 2026's UK Penny Stocks To Watch

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market pressures, there remain opportunities for investors willing to explore beyond the mainstream indices. Penny stocks, often representing smaller or newer companies, can still offer potential growth when they are underpinned by strong financials and sound fundamentals.
OM:HACK
OM:HACKEntertainment

Is Hacksaw (OM:HACK) Using Its bet365 Pennsylvania Launch To Reset Its US iGaming Strategy?

In January 2026, Hacksaw Gaming announced it had launched in Pennsylvania through an expanded partnership with bet365, with titles such as Wanted Dead or a Wild, Le Bandit, Stormforged and Densho now available via Light & Wonder’s platform. This expansion gives Hacksaw Gaming broader exposure to the regulated US iGaming market, potentially strengthening brand recognition through bet365’s established customer base in Pennsylvania. Next, we’ll examine how this deeper bet365 partnership and...
OM:BOL
OM:BOLMetals and Mining

European Value Stocks Priced Below Estimated Worth In January 2026

As the European market continues to show optimism with major indexes like the STOXX Europe 600 and Germany's DAX climbing, investors are increasingly attentive to opportunities in value stocks. In this environment of economic strengthening and favorable interest rates, identifying stocks priced below their estimated worth can offer potential advantages for those seeking to capitalize on undervaluation.